Almost 1 in 6 patients undergoing percutaneous left atrial appendage (LAA) closure die within a year, new registry data show, suggesting that assessment of life expectancy may be needed before ...
A left atrial appendage (LAA) closure device provides long-term thromboembolic protection that is equivalent to direct oral anticoagulants after ablation for atrial fibrillation (AF), along with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results